What are the Challenges in Achieving High Specificity?
Despite advancements, achieving high specificity in cancer care remains challenging. Tumor heterogeneity, where cancer cells within the same tumor exhibit different characteristics, complicates the development of highly specific diagnostics and treatments. Additionally, some cancer biomarkers are also present in normal cells, leading to potential false positives.
